Penumbra (PEN) Retained Earnings (2014 - 2026)
Penumbra's (PEN) quarterly Retained Earnings came in at $270.3 million in Q1 2026, down 75.8% year-on-year from $1.1 billion in Q1 2025, and up 6116.08% on a QoQ basis from $4.3 million in Q4 2025.
Penumbra (PEN) Retained Earnings (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Retained Earnings data on file, last reported at $270.3 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 75.8% year-over-year to $270.3 million in Q1 2026; TTM through Mar 2026 was $270.3 million, a 75.8% decrease from a year earlier, with the FY2025 full-year figure at $4.3 million, up 174.41% from the prior year.
- Retained Earnings for Q1 2026 stood at $270.3 million, up from $4.3 million in the prior quarter.
- Over the last five years, Retained Earnings for PEN reached as high as $1.2 billion in Q3 2025 and fell as low as -$8.1 million in Q4 2022.
- Historically, Retained Earnings has averaged $341.2 million across 5 years, with a median of $80.6 million in 2023.
- Across the five-year window, Retained Earnings plunged 113.19% in 2023 and soared 121096.37% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$8.1 million in 2022, then soared by 12990.18% to $1.0 billion in 2023, then sank by 100.56% to -$5.8 million in 2024, then jumped by 174.41% to $4.3 million in 2025, then soared by 6116.08% to $270.3 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $270.3 million in Q1 2026, $4.3 million in Q4 2025, and $1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 270.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 270.28 Mn |
| Dec 31, 2025 | 4.35 Mn |
| Sep 30, 2025 | 1.17 Bn |
| Jun 30, 2025 | 3.16 Mn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | -5.84 Mn |
| Sep 30, 2024 | -963,000.00 |
| Jun 30, 2024 | 85.66 Mn |
| Mar 31, 2024 | 145.86 Mn |
| Dec 31, 2023 | 1.05 Bn |
| Sep 30, 2023 | 80.64 Mn |
| Jun 30, 2023 | -5.58 Mn |
| Mar 31, 2023 | -6.86 Mn |
| Dec 31, 2022 | -8.12 Mn |
| Sep 30, 2022 | 947.04 Mn |
| Jun 30, 2022 | 42.30 Mn |
| Mar 31, 2022 | 919.25 Mn |
| Dec 31, 2021 | 910.61 Mn |
| Sep 30, 2021 | 621.46 Mn |
| Mar 31, 2021 | 52.46 Mn |